T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$1.3B |
| 2 |
American Airlines Group
AAL
|
+$853M |
| 3 |
Intuitive Surgical
ISRG
|
+$816M |
| 4 |
Morgan Stanley
MS
|
+$681M |
| 5 |
Wynn Resorts
WYNN
|
+$622M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$1.4B |
| 2 |
eBay
EBAY
|
+$763M |
| 3 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$760M |
| 4 |
Broadcom
AVGO
|
+$757M |
| 5 |
US Bancorp
USB
|
+$686M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.95% |
| 2 | Consumer Discretionary | 13.63% |
| 3 | Financials | 12.8% |
| 4 | Industrials | 12.27% |
| 5 | Technology | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1551
iShare MSCI Eurozone ETF
EZU
$9.96B
| $2.16M | ﹤0.01% |
51,000
+15,100
| +42% | +$648K |
|
|
NSM
1552
DELISTED
Nationstar Mortgage Holdings
NSM
| $2.15M | ﹤0.01% |
59,200
-284,900
| -83% | -$9.44M |
|
|
CYN
1553
DELISTED
CITY NATIONAL CORPORATION
CYN
| $2.15M | ﹤0.01% |
28,350
| – | – |
|
1554
Arch Capital
ACGL
$33.7B
| $2.14M | ﹤0.01% |
111,729
-36,408
| -25% | -$693K |
|
1555
Lear
LEA
$8.29B
| $2.12M | ﹤0.01% |
23,700
+1,100
| +5% | +$94.7K |
|
1556
Extra Space Storage
EXR
$31.4B
| $2.11M | ﹤0.01% |
39,600
| – | – |
|
1557
Herbalife
HLF
$1.28B
| $2.11M | ﹤0.01% |
65,262
+200
| +0.3% | +$6.13K |
|
1558
Avnet
AVT
$7.84B
| $2.09M | ﹤0.01% |
47,098
+6,200
| +15% | +$273K |
|
1559
HNI Corp
HNI
$3.53B
| $2.06M | ﹤0.01% |
52,580
+3,000
| +6% | +$110K |
|
1560
Albemarle
ALB
$16B
| $2.03M | ﹤0.01% |
28,340
+1,300
| +5% | +$89.2K |
|
|
MDR
1561
DELISTED
McDermott International
MDR
| $2.02M | ﹤0.01% |
83,283
+1,800
| +2% | +$39.6K |
|
1562
Arthur J. Gallagher & Co
AJG
$64.6B
| $2.02M | ﹤0.01% |
43,260
+100
| +0.2% | +$4.56K |
|
1563
ENI
E
$79.7B
| $2.02M | ﹤0.01% |
36,700
+1,400
| +4% | +$72.4K |
|
1564
National Fuel Gas
NFG
$7.81B
| $2.01M | ﹤0.01% |
25,693
+1,371
| +6% | +$101K |
|
1565
AXIS Capital
AXS
$7.39B
| $2.01M | ﹤0.01% |
45,300
+7,200
| +19% | +$329K |
|
|
CCRN
1566
DELISTED
Cross Country Healthcare
CCRN
| $1.98M | ﹤0.01% |
+304,300
| New | +$2.01M |
|
|
SUNE
1567
DELISTED
SUNEDISON, INC COM
SUNE
| $1.98M | ﹤0.01% |
87,500
+4,700
| +6% | +$91.3K |
|
1568
Alliant Energy
LNT
$18.3B
| $1.95M | ﹤0.01% |
64,096
+2,600
| +4% | +$75.3K |
|
|
Y
1569
DELISTED
Alleghany Corp
Y
| $1.94M | ﹤0.01% |
4,436
+100
| +2% | +$41.8K |
|
1570
Popular Inc
BPOP
$11.3B
| $1.93M | ﹤0.01% |
56,405
+2,300
| +4% | +$70.9K |
|
1571
TSMC
TSM
$2.21T
| $1.93M | ﹤0.01% |
90,060
-2,149,746
| -96% | -$44.3M |
|
1572
Canadian National Railway
CNI
$76.9B
| $1.92M | ﹤0.01% |
29,420
+16,300
| +124% | +$969K |
|
1573
AGCO
AGCO
$7.05B
| $1.89M | ﹤0.01% |
33,650
+2,200
| +7% | +$122K |
|
1574
Magnachip Semiconductor
MX
$138M
| $1.89M | ﹤0.01% |
133,700
| – | – |
|
1575
Casey's General Stores
CASY
$31.5B
| $1.88M | ﹤0.01% |
26,700
| – | – |
|
Similar funds
T. Rowe Price Associates's Q2 2014 Portfolio in Review
As of Q2 2014, T. Rowe Price Associates held 2,596 positions worth $463B, up 3.9% from $445B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
T. Rowe Price Associates's Q2 2014 filing shows 97 new, 1,091 increased, 793 reduced and 67 closed positions. Its largest new stake was Teva Pharmaceuticals: 4,638,481 shares worth $243M. The largest sale was Procter & Gamble, an estimated $1.4B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2014 buy was Teva Pharmaceuticals: 4,638,481 shares worth $243M.
- T. Rowe Price Associates added most to Allergan Inc in Q2 2014, an estimated $1.3B increase.
- T. Rowe Price Associates's biggest Q2 2014 reduction was Procter & Gamble, cutting an estimated $1.4B.
- T. Rowe Price Associates fully exited Santander in Q2 2014, selling an estimated $134M.
- T. Rowe Price Associates's ten largest holdings make up 12% of its $463B portfolio in Q2 2014.
- T. Rowe Price Associates opened 97 new positions and closed 67 in Q2 2014.
- T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $463B.
Based on T. Rowe Price Associates's 13F filing for Q2 2014, filed 14 Aug 2014.